Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Neuralink Corp

Clinicaltrial registered10 Nov 2026

Neuralink Corp

10 Nov 2026: Trial registered · An Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices in Spinal Cord Injury, Amyotrophic Lateral Sclerosis, and Chronic Ischemic Stroke. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
10 Nov 2026
Title
An Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices in Spinal Cord Injury, Amyotrophic Lateral Sclerosis, and Chronic Ischemic Stroke
Conditions
Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Chronic Ischemic Stroke, Tetraplegia/Tetraparesis
Phase
Not applicable
Study Type
Interventional
Status
Recruiting
Countries
United States
Country
United States
Reference
NCT07929792
Location
United States
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Neuralink Corp

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.